Literature DB >> 2905162

Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension.

J L Pool, E B Nelson, A A Taylor, J R Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2905162

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN： 0262-8767


× No keyword cloud information.
  2 in total

1.  The influence of food on the oral bioavailability of terazosin.

Authors:  J J McNeil; O H Drummer; K Raymond; E L Conway; W J Louis
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

Review 2.  Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?

Authors:  M Ligueros; R Unwin; M Wilkins
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.